Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM (T2DM)

This study has been completed.
Information provided by (Responsible Party):
GlaxoSmithKline Identifier:
First received: July 12, 2012
Last updated: April 24, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2014
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):